Report Quantifies Misdiagnosis of Dangerous Diseases in the United States
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, July 25, 2023 -- Misdiagnosis of dangerous diseases results in an estimated 795,000 Americans with permanent morbidity or mortality, according to a study published online July 17 in BMJ Quality & Safety.
David E. Newman-Toker, M.D., Ph.D., from the Johns Hopkins School of Medicine in Baltimore, and colleagues conducted a cross-sectional analysis of U.S.-based nationally representative observation data to estimate the annual U.S. burden of serious misdiagnosis-related harms (permanent morbidity and mortality). Annual incident vascular events and infections were estimated from 21.5 million sampled U.S. hospital discharges (2012 to 2014), and annual new cancers were obtained from U.S.-based registries.
The annual U.S. incidence was 6.0 million vascular events, 6.2 million infections, and 1.5 million cancers. The researchers found that per 'Big Three' (15 major vascular events, infections, and cancers) dangerous disease cases, the weighted mean error rate was 11.1 percent and serious harm rate was 4.4 percent. Total serious harms annually in the United States was extrapolated to be 795,000 for all diseases (including non-'Big Three' dangerous disease categories). Using more conservative assumptions, sensitivity analyses estimated 549,000 serious harms. The 15 dangerous diseases accounted for 50.7 percent of total serious harms, with the top five accounting for 38.7 percent.
"Research and quality improvement programs should include a strong focus on prompt diagnosis of vascular events, infections and cancers, with an emphasis on the top 15 dangerous diseases identified in this study, which together likely account for half of all serious misdiagnosis-related harms," the authors write.
One author is inventor on a provisional patent and serves as medical-legal consultant.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.